valsartan voluntary recall

Date: 08/10/18

On July 27, 2018, the U.S. Food and Drug Administration (FDA) updated their announcement regarding the valsartan voluntary recall to include additional manufacturers.

The FDA press release states the following:

FDA is updating health care professionals and patients after discovering that several additional companies that repackage drug products are also recalling valsartan-containing products. FDA has product recall information from three additional repackagers of valsartan-containing products made by Teva Pharmaceuticals and Prinston Pharmaceuticals Inc. – labeled as A-S Medication Solutions LLC, AvKARE and RemedyRepack – and the agency has added them to the recalled products list. Two of these companies, A-S Medication and RemedyRepack, may also distribute valsartan products not affected by the recall. The agency is confirming this information and will provide an update once it is available.

If you have any questions or concerns about Envolve Pharmacy Solutions’ response to the product recall, please contact Nelson Aragon, Pharm D, Drug Utilization Review Clinical Pharmacist, at (800) 225-2573, ext. 809-3034 or e-mail at Nelson.Aragon@envolvehealth.com, or contact Taline Jaghasspanian, Pharm D, Manager, Clinical Pharmacy Operations, at (818) 676-6959, or email at Taline.Jaghasspanian@centene.com.